2-vinyl-4,6-diamino-1,3,5-triazine: used to create a DNA-imprinted polymer; structure in first source
ID Source | ID |
---|---|
PubMed CID | 586156 |
SCHEMBL ID | 139174 |
MeSH ID | M0485407 |
Synonym |
---|
6-vinyl-1,3,5-triazine-2,4-diamine , |
6-ethenyl-1,3,5-triazine-2,4-diamine |
FT-0692931 |
2-vinyl-4,6-diamino-1,3,5-triazine |
3194-70-5 |
4,6-diamino-2-vinyl-1,3,5-triazine |
V0057 |
A821069 |
AKOS006229574 |
SCHEMBL139174 |
2-vinyl-4,6-diamino-s-triazin |
ZXLYUNPVVODNRE-UHFFFAOYSA-N |
6-vinyl-1,3,5-triazine-2,4-diamine # |
2-vinyl-4,6-diamino-s-triazine |
mfcd00059935 |
DTXSID60342953 |
2-vinyl-4,6-diamino-1,3,5-triazine, >/=95% |
1,3,5-triazine-2,4-diamine, 6-ethenyl- |
SB73278 |
T72286 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 7 (70.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (17.58) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |